CRISPR-Cas9 Screening Identifies Therapeutic Targets for AML1-ETO Positive Leukemia

被引：0
|
作者：
Guo, Chengcai [1 ]
Liu, Yu [1 ]
Rao, Qing [1 ]
Qiu, Shaowei [2 ]
Gu, Runxia [2 ]
Wang, Min [2 ]
Wang, Jianxiang [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Natl Clin Res Ctr Blood Dis, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol, Haihe Lab Cell Ecosyst,Inst Hematol & Blood Dis H, Tianjin, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-179262
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] CRISPR-Cas9 Screening Identifies Therapeutic Targets for AML1-ETO Positive Leukemia
    Guo, Chengcai
    Liu, Yu
    Rao, Qing
    Gu, Runxia
    Qiu, Shaowei
    Wang, Min
    Wang, Jianxiang
    BLOOD, 2024, 144 : 2734 - 2735
  • [2] CRISPR-Cas9 screening identifies the role of FER as a tumor suppressor
    Wang, Jiaqi
    Yang, Ran
    Wang, Fengsheng
    Zhang, Junlei
    Dong, Yutong
    Wang, Jiangjun
    Yu, Meng
    Xu, Yixiao
    Liu, Lianlian
    Cheng, Yuda
    Zhang, Chen
    Yang, Yi
    Yang, Wubin
    Wang, Jiali
    Chen, Guangxing
    Huang, Yi
    Tian, Yanping
    Jian, Rui
    Ni, Bing
    Wu, Wei
    Ruan, Yan
    JOURNAL OF PATHOLOGY, 2025, 265 (02): : 158 - 171
  • [3] Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens
    Behan, Fiona M.
    Iorio, Francesco
    Picco, Gabriele
    Goncalves, Emanuel
    Beaver, Charlotte M.
    Migliardi, Giorgia
    Santos, Rita
    Rao, Yanhua
    Sassi, Francesco
    Pinnelli, Marika
    Ansari, Rizwan
    Harper, Sarah
    Jackson, David Adam
    Mcrae, Rebecca
    Pooley, Rachel
    Wilkinson, Piers
    van der Meer, Dieudonne
    Dow, David
    Buser-Doepner, Carolyn
    Bertotti, Andrea
    Trusolino, Livio
    Stronach, Euan A.
    Saez-Rodriguez, Julio
    Yusa, Kosuke
    Garnett, Mathew J.
    NATURE, 2019, 568 (7753) : 511 - +
  • [4] Genome-wide CRISPR-Cas9 screening identifies genetic vulnerabilities and potential therapeutic targets in castration resistant prostate cancer
    Haldrup, Jakob
    Schmidt, Linnea
    Pedersen, Jakob S.
    Sorensen, Karina D.
    CANCER RESEARCH, 2018, 78 (13)
  • [5] AML1-ETO targets and suppresses cathepsin G, a serine protease, which is able to degrade AML1-ETO in t(8;21) acute myeloid leukemia
    W Jin
    K Wu
    Y-Z Li
    W-T Yang
    B Zou
    F Zhang
    J Zhang
    K-K Wang
    Oncogene, 2013, 32 : 1978 - 1987
  • [6] AML1-ETO targets and suppresses cathepsin G, a serine protease, which is able to degrade AML1-ETO in t(8;21) acute myeloid leukemia
    Jin, W.
    Wu, K.
    Li, Y-Z
    Yang, W-T
    Zou, B.
    Zhang, F.
    Zhang, J.
    Wang, K-K
    ONCOGENE, 2013, 32 (15) : 1978 - 1987
  • [7] AML1-ETO driven acute leukemia: insights into pathogenesis and potential therapeutic approaches
    Megan A. Hatlen
    Lan Wang
    Stephen D. Nimer
    Frontiers of Medicine, 2012, 6 (3) : 248 - 262
  • [8] Potential Therapeutic Approaches for the Treatment of Acute Myeloid Leukemia with AML1-ETO Translocation
    Arora, Rashi
    Sawney, Sharad
    Saluja, Daman
    CURRENT CANCER DRUG TARGETS, 2016, 16 (03) : 215 - 225
  • [9] A Case of Acute Mixed Cell Leukemia Resembling AML1-ETO Positive Acute Myeloid Leukemia
    Li, Ruimin
    Wu, Yiping
    Zhang, Xiaofang
    Wang, Lihua
    Zhang, Yungang
    Xiao, Heng
    CLINICAL LABORATORY, 2023, 69 (04) : 817 - 820
  • [10] Advances in therapeutic application of CRISPR-Cas9
    Sun, Jinyu
    Wang, Jianchu
    Zheng, Donghui
    Hu, Xiaorong
    BRIEFINGS IN FUNCTIONAL GENOMICS, 2020, 19 (03) : 164 - 174
12345